Phase II clinical trial - Sarcomes
BFR ESS 01
Sarcomes
Ouvert depuis le: 10.05.2022
Site: Paris
Public cible
Adulte
Randomized Comparative Prospective Multicentre Phase II Trial Evaluating Clinical Impact of Interruption VS Maintenance of AI in Patients With Locally Advanced/ Metastatic LGESS
Description de l'essai
The primary objective is to compare the progression-free survival (PFS) between aromatase inhibitors interruption and aromatase inhibitors maintenance strategies in patients with a locally advanced or metastatic Low Grade Endometrial Stromal Sarcoma (LGESS).
Liens utiles
